Department of Endocrinology, Royal Prince Alfred Hospital and University of Sydney, Sydney, New South Wales, Australia.
Monash University, Melbourne, Victoria, Australia.
Diabetes Care. 2024 Dec 1;47(12):2085-2092. doi: 10.2337/dc23-2214.
We evaluated associations between early-pregnancy oral glucose tolerance test (OGTT) glucose and complications in the Treatment of Booking Gestational Diabetes Mellitus (TOBOGM) cohort to inform prognostic OGTT thresholds.
Individuals with risk factors for hyperglycemia were recruited for an international, multicenter, randomized controlled gestational diabetes mellitus (GDM) (World Health Organization 2013 criteria) treatment trial. A 2-h 75-g OGTT was performed at <20 weeks' gestation. Individuals with early treated hyperglycemia in pregnancy were excluded from the primary analysis. Early OGTT glucose concentrations were analyzed continuously and in glycemic categories (normal, low band, and high band).
Overall, 3,645 individuals had an OGTT at (mean ± SD) 15.6 ± 2.5 weeks. For each 1-SD increase in fasting, 1-h, and 2-h glucose values, there were continuous positive associations with late GDM: adjusted odds ratio (aOR) 2.04 (95% CI 1.82-2.27), 3.05 (2.72-3.43), and 2.21 (1.99-2.45), respectively. There were continuous positive associations between 1-h and 2-h glucose and the perinatal composite (birth <37 + 0 weeks, birth trauma, birth weight ≥4,500 g, respiratory distress, phototherapy requirement, stillbirth/neonatal death, and shoulder dystocia), with aOR 1.15 (95% CI 1.04-1.26) and 1.14 (1.04-1.25), respectively, and with large-for-gestational-age offspring, with aOR 1.18 (1.06-1.31) and 1.26 (1.01-1.25), respectively. Significant associations were also observed between 1-h glucose and cesarean section and between fasting and 2-h glucose and neonatal hypoglycemia. In categorical analysis, only the high-band 1-h glucose (≥10.6 mmol/L [191 mg/dL]) predicted the perinatal composite.
There is a continuous positive association between early-pregnancy OGTT glucose and complications. In individuals with hyperglycemia risk factors, only the high-glycemic-band 1-h glucose corresponded to increased risk of major perinatal complications.
我们评估了早孕期口服葡萄糖耐量试验(OGTT)血糖与治疗妊娠糖尿病(GDM)试验(TOBOGM)队列中并发症之间的关系,以便为预测性 OGTT 阈值提供信息。
对有高血糖危险因素的个体进行了一项国际、多中心、随机对照 GDM(世界卫生组织 2013 年标准)治疗试验的招募。在妊娠<20 周时进行 2 小时 75g OGTT。在主要分析中排除了早孕期治疗的高血糖个体。连续分析和按血糖类别(正常、低水平和高水平)分析早 OGTT 血糖浓度。
总体而言,3645 名个体在(平均±标准差)15.6±2.5 周时进行了 OGTT。空腹、1 小时和 2 小时血糖值每增加 1 个标准差,与晚期 GDM 均呈连续正相关:校正比值比(aOR)分别为 2.04(95%CI 1.82-2.27)、3.05(2.72-3.43)和 2.21(1.99-2.45)。1 小时和 2 小时血糖与围产期综合指标(胎龄<37+0 周、出生创伤、出生体重≥4500g、呼吸窘迫、光疗需求、死胎/新生儿死亡和肩难产)呈连续正相关,aOR 分别为 1.15(95%CI 1.04-1.26)和 1.14(1.04-1.25),与巨大儿也呈连续正相关,aOR 分别为 1.18(1.06-1.31)和 1.26(1.01-1.25)。1 小时血糖与剖宫产,空腹和 2 小时血糖与新生儿低血糖之间也存在显著关联。在分类分析中,只有高水平的 1 小时血糖(≥10.6mmol/L[191mg/dL])预测了围产期综合指标。
早孕期 OGTT 血糖与并发症之间存在连续正相关。在有高血糖危险因素的个体中,只有高血糖水平的 1 小时血糖与主要围产期并发症的风险增加相关。